CADL
Price
$12.27
Change
+$0.29 (+2.42%)
Updated
May 21 closing price
KRRO
Price
$50.80
Change
-$3.80 (-6.96%)
Updated
May 21 closing price
Ad is loading...

CADL vs KRRO

Header iconCADL vs KRRO Comparison
Open Charts CADL vs KRROBanner chart's image
Candel Therapeutics
Price$12.27
Change+$0.29 (+2.42%)
Volume$429.81K
CapitalizationN/A
Korro Bio
Price$50.80
Change-$3.80 (-6.96%)
Volume$22.72K
CapitalizationN/A
View a ticker or compare two or three
CADL vs KRRO Comparison Chart

Loading...

CADLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KRRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CADL vs. KRRO commentary
May 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a StrongSell and KRRO is a Hold.

COMPARISON
Comparison
May 22, 2024
Stock price -- (CADL: $11.98 vs. KRRO: $54.60)
Brand notoriety: CADL and KRRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 6% vs. KRRO: 99%
Market capitalization -- CADL: $356.34M vs. KRRO: $506.31M
CADL [@Biotechnology] is valued at $356.34M. KRRO’s [@Biotechnology] market capitalization is $506.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileKRRO’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • KRRO’s FA Score: 0 green, 5 red.
According to our system of comparison, KRRO is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while KRRO’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 4 bearish.
  • KRRO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CADL is a better buy in the short-term than KRRO.

Price Growth

CADL (@Biotechnology) experienced а +17.45% price change this week, while KRRO (@Biotechnology) price change was +8.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.73%. For the same industry, the average monthly price growth was +6.30%, and the average quarterly price growth was +63.23%.

Reported Earning Dates

CADL is expected to report earnings on May 14, 2024.

KRRO is expected to report earnings on Mar 27, 2024.

Industries' Descriptions

@Biotechnology (+1.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CADL with price predictions.
OPEN
A.I.dvisor published
a Summary for KRRO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
KRRO($506M) has a higher market cap than CADL($356M). CADL YTD gains are higher at: 714.966 vs. KRRO (13.916).
CADLKRROCADL / KRRO
Capitalization356M506M70%
EBITDAN/AN/A-
Gain YTD714.96613.9165,138%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
CADLKRRO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CADLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KRRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBCX67.420.27
+0.40%
Rydex Basic Materials C
BRBCX13.580.02
+0.15%
BlackRock Tactical Opportunities Inv C
KCVIX17.67N/A
N/A
Knights of Columbus Large Cap Value I
HDVTX10.85-0.01
-0.09%
Hartford International Equity R5
JVAIX38.47-0.23
-0.59%
JPMorgan Value Advantage L

CADL and

Correlation & Price change

A.I.dvisor tells us that CADL and MDGL have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CADL and MDGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+4.17%
MDGL - CADL
33%
Poorly correlated
+5.47%
KRRO - CADL
31%
Poorly correlated
-0.11%
INKT - CADL
29%
Poorly correlated
N/A
GTHX - CADL
27%
Poorly correlated
+0.44%
DSGN - CADL
27%
Poorly correlated
-0.23%
More

KRRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRRO has been loosely correlated with ALPN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KRRO jumps, then ALPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRRO
1D Price
Change %
KRRO100%
-0.11%
ALPN - KRRO
40%
Loosely correlated
N/A
CDIO - KRRO
35%
Loosely correlated
-5.47%
IMTX - KRRO
33%
Loosely correlated
-0.18%
HOWL - KRRO
33%
Loosely correlated
+1.27%
GLPG - KRRO
33%
Poorly correlated
-1.52%
More